Kirkland & Ellis is advising buyer group Mountain Tiger International on its approximately $1 billion bid to take over Bona Film Group, a leading movie producer and distributor in China, with Simpson Thacher & Bartlett serving as the Chinese studio’s U.S. legal counsel.


Shearman & Sterling is acting for the independent committee of Bona’s board of directors in matters related to U.S. law, while Davis Polk & Wardwell is representing Barclays Bank, the committee’s financial advisor. For concerns involving Cayman Islands law, Conyers Dill & Pearman is handling the buyer group’s interests, while Maples and Calder is advising Bona’s independent committee.

The go-private deal, which is subject to shareholder approval, is expected to be completed in the second quarter of 2016. Led by Bona chairman and CEO Dong Yu, the buyer group also includes subsidiaries of China’s two Internet giants, Alibaba and Tencent, as well as investment companies Sequoia Capital, Fosun International and SAIF Parnters.

Hong Kong-based corporate partners David Zhang and Jesse Sheley are leading K&E’s team while Hong Kong partner Chris Lin is heading the STB team.

M&A specialist Stephanie Tang is leading the Shearman & Sterling team, with help from fellow partners Larry Crouch, Richard Hsu and Stephen Hibbard. Davis Polk partner Miranda So is overseeing the transaction for Davis Polk.

After the deal closes, the ownership group will include Yu and other entities that already hold almost 72 percent of Bona, which runs 30 movie theaters and manages a stable of popular stars in China. Its international film distribution business covers Korea and the U.S. as well as Southeast Asia and Europe. Bona was one of the producers of this year’s The Martian, starring Hollywood leading man Matt Damon, and the 2013 wuxia film The Grandmaster, helmed by art-house cinema director Wong Kar-wai.

Related Articles

海问、凯易助力港交所18A企业第一宗反向收购案例(ZH/EN)

近日,港交所18A上市企业嘉和生物宣布与亿腾医药达成合并协议,合并后企业将更名为亿腾嘉和医药集团有限公司。海问律师事务所担任嘉和生物的法律顾问,凯易国际律师事务所则代表亿腾医药参与交易。

礼德、富而德、凯易助力复宏汉霖54亿港元私有化交易(ZH/EN)

上海复星医药日前宣布,其控股子公司复星新药拟吸收合并及私有化港交所上市公司复宏汉霖。礼德律师事务所为复星提供服务;富而德律师事务所代表复宏汉霖参与交易;凯易国际律师事务所则为财务顾问中金公司提供法律意见。

中概股接连迎来两宗重大交易,汉坤、凯易等扮演领衔角色(ZH/EN)

过去两周,来自中国湖北武汉的超跑电动车制造商路特斯,以及来自湖南长沙的互联网券商微牛,先后通过SPAC合并交易实现在美国纳斯达克上市。